Yüklüyor......
Evaluation of degarelix in the management of prostate cancer
Medical castration using gonadotropin-releasing hormone (GnRH) receptor agonists currently provides the mainstay of androgen deprivation therapy for prostate cancer. Although effective, these agents only reduce testosterone levels after a delay of 14 to 21 days; they also cause an initial surge in t...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3004563/ https://ncbi.nlm.nih.gov/pubmed/21188095 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|